GlassScriptPhysician profile
Megan Jimenez
NPI 1417369315
$68,240.13
in general payments reported to CMS, 2019-2025
8 companies · $18K in 2025
The $18K reported for 2025 was more than what 91% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31K · 2020: $13K · 2021: $56.09 · 2022: $3,418 · 2023: $2,100 · 2024: $75.51 · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $14K · Travel and Lodging: $4,732 · Food and Beverage: $1,844.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,912.50 |
| Travel and Lodging | $4,732.33 |
| Food and Beverage | $1,844.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $35,876.48 | 2019-2025 | Q-Fix, Spatial Frame, Fast-Fix |
| Arthrex, INC. | $23,872.51 | 2019-2025 | |
| Elite Orthopedics, LLC | $3,267.87 | 2019-2020 | |
| Cgg Medical INC | $3,143.89 | 2020-2023 | |
| Invictus Surgical Incorporated | $1,004.10 | 2024-2025 | |
| Stryker Corporation | $786.64 | 2019-2021 | |
| Miach Orthopaedics, INC. | $144.40 | 2023 | |
| Davol INC. | $144.24 | 2023 | Arista Ah Flexitip |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Megan Jimenez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.